ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...

A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting. ... Read More The post Dr Boreham’s Crucible: A rival may be circling, ...

Stocks in this week’s article are Amphenol APH, GE Aerospace GE, ResMed RMD and Ameriprise Financial AMP. Add These GARP ...

Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.

If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, try the growth at a reasonable price or GARP strategy. The strategy helps investors gain ...

Around 30 million adults in the US have obstructive sleep apnea (OSA) and about 80% of them are undiagnosed. That means millions of people are suffering and might not realize their snoring or chronic ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

RBC Capital noted that ResMed achieved robust growth across all markets while continuing to deliver gross margin improvement and operating leverage. The firm made minor increases to its forecasts, ...

Investing.com - KeyBanc Capital Markets raised its price target on ResMed (NYSE:RMD) to $302.00 from $299.00 on Friday, while maintaining an Overweight rating on the medical equipment manufacturer’s ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Intuitive Machines’ main opportunity is the commercialization of travel to the Moon, requiring landers, rovers, and communication relay equipment and services. The first two missions attempting to ...